Ovarian Carcinosarcoma

specific

An aggressive, high-grade malignant tumor that arises from the ovary and is composed of carcinomatous and sarcomatous elements. The vast majority of cases are malignant mixed mesodermal (Mullerian) tumors that originate from the Mullerian ducts. Exceedingly rare cases that arise from mesonephric remnants have also been described.

59

Centers

6

Active Trials

Cancer Funding

Top Centers for Ovarian Carcinosarcoma(59)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.1
2
NCI Comprehensive
High-Volume Research Center
71.1
3
NCI Comprehensive
High-Volume Research Center
71.1
4
High-Volume Research Center
71.1
5
High-Volume Research Center
71.1
6
High-Volume Research Center
71.1
7
NCI Comprehensive
48.6
848.6
9
NCI Comprehensive
48.6
10
NCI Comprehensive
48.6
11
NCI Comprehensive
48.6
12
NCI Comprehensive
48.6
13
NCI Comprehensive
48.6
14
NCI Comprehensive
48.6
15
NCI Comprehensive
48.6
16
NCI Comprehensive
48.6
1748.6
1848.6
1948.6
20
NCI Comprehensive
48.6
2148.6
22
NCI Comprehensive
48.6
23
NCI Comprehensive
48.6
24
NCI Comprehensive
48.6
25
NCI Comprehensive
48.6
26
NCI Comprehensive
48.6
27
NCI Comprehensive
48.6
28
NCI Comprehensive
48.6
29
NCI Comprehensive
48.6
3048.6
3148.6
32
NCI Comprehensive
48.6
33
Cedars-Sinai CancerLos Angeles, CA
48.6
3448.6
3548.6
36
NCI Comprehensive
48.6
3748.6
3848.6
39
NCI Comprehensive
48.6
40
NCI Comprehensive
48.6
41
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
48.6
4248.6
4348.6
44
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
48.6
45
NCI Comprehensive
48.6
4648.6
4748.6
4848.6
4948.6
5048.6
5148.6
5248.6
5348.6
5448.6
5548.6
5648.6
5748.6
58
BC CancerVancouver, BC
48.6
5948.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →